Inventor
TREHAN AMAN
US25 patents
⚠️ This page may combine multiple inventors who share the name “TREHAN AMAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SOMERSET THERAPEUTICS LLC
24 patentsUS12156868B2Dec 3, 2024
Formulations of pilocarpine and brimonidine compounds and related methods
SOMERSET THERAPEUTICS LLC1 citations72
US11969410B2Apr 30, 2024
Low pH pilocarpine and brimonidine compound formulations and related methods
SOMERSET THERAPEUTICS LLC1 citations72
US11857539B2Jan 2, 2024
Gel ophthalmic formulations of pilocarpine and brimonidine compounds and related methods
SOMERSET THERAPEUTICS LLC1 citations72
US11564931B2Jan 31, 2023
Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties
SOMERSET THERAPEUTICS LLC1 citations72
US11400100B2Aug 2, 2022
Effective benzalkonium chloride-free bimatoprost ophthalmic compositions
SOMERSET THERAPEUTICS LLC1 citations72
US11298315B2Apr 12, 2022
Triamcinolone and moxifloxacin compositions
SOMERSET THERAPEUTICS LLC3 citations72
US12064440B2Aug 20, 2024
Ophthalmic gel compositions of bimatoprost and timolol and associated methods
SOMERSET THERAPEUTICS LLC0 citations62
US12042502B2Jul 23, 2024
Enhanced penetration ophthalmic compositions of bimatoprost and timolol
SOMERSET THERAPEUTICS LLC0 citations62
US12016855B2Jun 25, 2024
Prednisolone and moxifloxacin compositions and methods
SOMERSET THERAPEUTICS LLC0 citations62
US11786538B2Oct 17, 2023
Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties
SOMERSET THERAPEUTICS LLC0 citations62
US11510930B2Nov 29, 2022
Gatifloxacin, prednisolone, and bromfenac compositions and methods
SOMERSET THERAPEUTICS LLC0 citations62
US11484538B2Nov 1, 2022
Bromfenac, prednisolone, and moxifloxacin compositions and methods
SOMERSET THERAPEUTICS LLC0 citations62
US11471403B2Oct 18, 2022
Limited particle size triamcinolone and moxifloxacin compositions and associated methods of use
SOMERSET THERAPEUTICS LLC0 citations62
US11446242B2Sep 20, 2022
Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods of use
SOMERSET THERAPEUTICS LLC0 citations62
US11439591B2Sep 13, 2022
Moxifloxacin and triamcinolone compositions and associated methods
SOMERSET THERAPEUTICS LLC0 citations62
US11382910B2Jul 12, 2022
Loteprednol and moxifloxacin compositions and methods
SOMERSET THERAPEUTICS LLC0 citations62
US11523987B2Dec 13, 2022
Trimcinolone and moxifloxacin methods
SOMERSET THERAPEUTICS LLC0 citations61
US11883382B2Jan 30, 2024
Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereof
SOMERSET THERAPEUTICS LLC0 citations60
US11793789B2Oct 24, 2023
Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrine
SOMERSET THERAPEUTICS LLC0 citations60
US11696910B2Jul 11, 2023
Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof
SOMERSET THERAPEUTICS LLC1 citations60
US12102632B2Oct 1, 2024
Quinolone dispersions
SOMERSET THERAPEUTICS LLC0 citations51
US11857538B2Jan 2, 2024
Stable pilocarpine formulations with modified buffer characteristics and related methods
SOMERSET THERAPEUTICS LLC0 citations51
US11850249B2Dec 26, 2023
Methods of efficiently reducing intraocular pressure
SOMERSET THERAPEUTICS LLC0 citations51
US12029729B2Jul 9, 2024
Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof
SOMERSET THERAPEUTICS LLC0 citations50